Toward a Basic Understanding of Diabetic Complications

Research output: Contribution to journalEditorial

9 Citations (Scopus)

Abstract

Diabetes mellitus presents a lifelong challenge to patients and their health care providers. Although Type I (insulin-dependent) and Type II (non-insulindependent) diabetes mellitus probably have different causes, patients with either form have an increased risk of microvascular, macrovascular, and neurologic complications. Many studies have examined or are addressing the relations between glycemic control (usually determined by levels of glycosylated hemoglobin) and the prevention or progression of these complications.1 Yet current therapy for patients with Type I or II diabetes rarely if ever normalizes blood glucose or glycosylated hemoglobin levels, and some patients will probably continue to have complications even when.

Original languageEnglish (US)
Pages (from-to)883-884
Number of pages2
JournalNew England Journal of Medicine
Volume325
Issue number12
DOIs
StatePublished - Sep 19 1991

Fingerprint

Diabetes Complications
Glycosylated Hemoglobin A
Diabetes Mellitus
Health Personnel
Nervous System
Blood Glucose
Insulin
Therapeutics

Cite this

Toward a Basic Understanding of Diabetic Complications. / Steffes, Michael W; Mauer, Michael.

In: New England Journal of Medicine, Vol. 325, No. 12, 19.09.1991, p. 883-884.

Research output: Contribution to journalEditorial

@article{1436903d1ade431ba7386b66983fda61,
title = "Toward a Basic Understanding of Diabetic Complications",
abstract = "Diabetes mellitus presents a lifelong challenge to patients and their health care providers. Although Type I (insulin-dependent) and Type II (non-insulindependent) diabetes mellitus probably have different causes, patients with either form have an increased risk of microvascular, macrovascular, and neurologic complications. Many studies have examined or are addressing the relations between glycemic control (usually determined by levels of glycosylated hemoglobin) and the prevention or progression of these complications.1 Yet current therapy for patients with Type I or II diabetes rarely if ever normalizes blood glucose or glycosylated hemoglobin levels, and some patients will probably continue to have complications even when.",
author = "Steffes, {Michael W} and Michael Mauer",
year = "1991",
month = "9",
day = "19",
doi = "10.1056/NEJM199109193251209",
language = "English (US)",
volume = "325",
pages = "883--884",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "12",

}

TY - JOUR

T1 - Toward a Basic Understanding of Diabetic Complications

AU - Steffes, Michael W

AU - Mauer, Michael

PY - 1991/9/19

Y1 - 1991/9/19

N2 - Diabetes mellitus presents a lifelong challenge to patients and their health care providers. Although Type I (insulin-dependent) and Type II (non-insulindependent) diabetes mellitus probably have different causes, patients with either form have an increased risk of microvascular, macrovascular, and neurologic complications. Many studies have examined or are addressing the relations between glycemic control (usually determined by levels of glycosylated hemoglobin) and the prevention or progression of these complications.1 Yet current therapy for patients with Type I or II diabetes rarely if ever normalizes blood glucose or glycosylated hemoglobin levels, and some patients will probably continue to have complications even when.

AB - Diabetes mellitus presents a lifelong challenge to patients and their health care providers. Although Type I (insulin-dependent) and Type II (non-insulindependent) diabetes mellitus probably have different causes, patients with either form have an increased risk of microvascular, macrovascular, and neurologic complications. Many studies have examined or are addressing the relations between glycemic control (usually determined by levels of glycosylated hemoglobin) and the prevention or progression of these complications.1 Yet current therapy for patients with Type I or II diabetes rarely if ever normalizes blood glucose or glycosylated hemoglobin levels, and some patients will probably continue to have complications even when.

UR - http://www.scopus.com/inward/record.url?scp=0026008886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026008886&partnerID=8YFLogxK

U2 - 10.1056/NEJM199109193251209

DO - 10.1056/NEJM199109193251209

M3 - Editorial

VL - 325

SP - 883

EP - 884

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 12

ER -